BCL3

BCL3

Target · Transcriptional coactivator

BCL3 BCL3 transcription coactivator · B-cell lymphoma 3 protein

BCL3 (B-cell lymphoma 3 protein) is an ankyrin repeat-containing transcriptional coactivator that contributes to the regulation of NF-kappa-B target genes and cell proliferation. It was previously known as B cell CLL/lymphoma 3 and carries the aliases D19S37 and BCL4. Browse Assay Genie's current range of BCL3 research reagents below, or read on for the biology behind the target.

Nuclear and cytoplasmicNF-kappa-B coactivatorProto-oncogene candidate
454 aa
Protein length
~48 kDa
Molecular weight
19q13.32
Gene locus
NFKB inhibitor
Protein family
Target information

What is BCL3 (BCL3 transcription coactivator)?

BCL3 contributes to the regulation of transcriptional activation of NF-kappa-B target genes, and its activity depends on where it sits in the cell. In the cytoplasm, it inhibits nuclear translocation of the NF-kappa-B p50 subunit. In the nucleus, it acts as a transcriptional activator that promotes transcription of NF-kappa-B target genes. It also contributes to the regulation of cell proliferation.

The BCL3 protein contains seven ankyrin repeats, which are most closely related to those found in I kappa B proteins, and HGNC places the gene in the NFKB inhibitor family and the wider ankyrin repeat domain containing group. It functions as a transcriptional co-activator through its association with NF-kappa-B homodimers. UniProt records the protein in the nucleus, the cytoplasm and the perinuclear region of the cytoplasm. The mouse ortholog is Bcl3.

The BCL3 gene is regarded as a proto-oncogene candidate. It was identified through its translocation into the immunoglobulin alpha-locus in some cases of B-cell leukaemia, which gave rise to the B cell CLL/lymphoma 3 name. Its expression can be induced by NF-kappa-B, forming part of an autoregulatory loop that controls the nuclear residence of p50 NF-kappa-B. HGNC also lists the locus among the microRNA protein coding host genes.

NF-kappa-B signalling

BCL3 modulates NF-kappa-B target gene transcription and the nuclear residence of p50, making it a focus for studying how this pathway is regulated.

Transcriptional regulation

As a coactivator acting through NF-kappa-B homodimers, BCL3 is used to examine how ankyrin repeat proteins shape gene expression.

Leukaemia and lymphoma research

BCL3 was identified through a translocation into the immunoglobulin alpha-locus in some B-cell leukaemias, and it remains a proto-oncogene candidate.

Cell proliferation studies

BCL3 contributes to the regulation of cell proliferation, so it is studied in work on growth control downstream of NF-kappa-B.

Background

BCL3 frequently asked questions

What does BCL3 do?

BCL3 contributes to the regulation of NF-kappa-B target gene transcription. In the cytoplasm it inhibits nuclear translocation of the p50 subunit, while in the nucleus it acts as a transcriptional activator of NF-kappa-B target genes. It also contributes to the regulation of cell proliferation.

What other names does BCL3 go by?

The HGNC-approved name is BCL3 transcription coactivator, and UniProt lists B-cell lymphoma 3 protein. Previous names include B cell CLL/lymphoma 3, and the gene has also been known by the symbols D19S37 and BCL4.

Is BCL3 linked to disease and conserved in other species?

BCL3 is a proto-oncogene candidate, identified by its translocation into the immunoglobulin alpha-locus in some cases of B-cell leukaemia. A mouse ortholog, Bcl3, exists. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other BCL-family proteins, transcriptional regulators and lymphoma-associated targets with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P20749; product specifications from Assay Genie datasheets.

BCL3 Product listing